Compare SRPT & DAVEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRPT | DAVEW |
|---|---|---|
| Founded | 1980 | 2015 |
| Country | United States | United States |
| Employees | N/A | 274 |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | N/A |
| IPO Year | 1997 | N/A |
| Metric | SRPT | DAVEW |
|---|---|---|
| Price | $21.22 | $0.81 |
| Analyst Decision | Hold | |
| Analyst Count | 29 | 0 |
| Target Price | ★ $26.23 | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 46.1K |
| Earning Date | 11-03-2025 | 03-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 3.12 |
| Revenue | ★ $2,413,715,000.00 | $319,355,000.00 |
| Revenue This Year | $13.83 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $34.00 |
| Revenue Growth | ★ 47.15 | 30.00 |
| 52 Week Low | $10.42 | $0.28 |
| 52 Week High | $129.84 | $0.32 |
| Indicator | SRPT | DAVEW |
|---|---|---|
| Relative Strength Index (RSI) | 52.00 | 47.09 |
| Support Level | $20.14 | $0.64 |
| Resistance Level | $22.97 | $0.72 |
| Average True Range (ATR) | 1.29 | 0.08 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 50.96 | 49.09 |
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit and finding side gigs.